Nan Leng
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Moyamoya disease diagnosis and treatment
Papers in
-
- Rheumatoid Arthritis Research and Therapies 2
- Systemic Lupus Erythematosus Research 2
- Spondyloarthritis Studies and Treatments 2
- Moyamoya disease diagnosis and treatment 1
-
- Signaling Pathways in Disease 1
- Co-authors
- Ping Zhu (5 shared papers)Dmitriy Ovcharenko (1 shared paper)Charles D. Johnson (1 shared paper)Kevin Kelnar (1 shared paper)David Brown (1 shared paper)Conghua Wang (1 shared paper)Lina Chen (1 shared paper)Rachel Morissette (1 shared paper)
- Journals
- Medicine (1 paper)European Journal of Cancer (1 paper)Microchimica Acta (1 paper)Archives of Biochemistry and Biophysics (1 paper)Journal of Clinical Immunology (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Nan Leng
14 papers receiving 473 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 166
- Rheumatology 132
- Immunology 122
- Molecular Biology 227
- Genetics 65
Countries citing papers authored by Nan Leng
This map shows the geographic impact of Nan Leng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Leng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Leng more than expected).
Fields of papers citing papers by Nan Leng
This network shows the impact of papers produced by Nan Leng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Leng. The network helps show where Nan Leng may publish in the future.
Co-authors
The 25 scholars most cited alongside Nan Leng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 186 | |
| 2 | 2011 | 141 | |
| 3 | 2013 | 69 | |
| 4 | 2015 | 40 | |
| 5 | 2009 | 13 | |
| 6 | 2018 | 8 | |
| 7 | 2017 | 7 | |
| 8 | [Prevalence of seronegative spondyloarthritis in the army force of China]. | 2004 | 5 |
| 9 | 2023 | 3 | |
| 10 | 2018 | 2 | |
| 11 | 2023 | 2 | |
| 12 | [Detection and clinical significance of serum antibody to ribosomal P protein in patients with systemic lupus erythematosus]. | 2005 | 2 |
| 13 | [The review study of Compound Muji Powder's effects on chronic patients with hepatitis B]. | 2005 | 1 |
| 14 | 2013 | 1 | |
| 15 | 2018 | 0 | |
| 16 | 2016 | 0 | |
| 17 | 2023 | 0 |
About Nan Leng
Nan Leng is a scholar working on Rheumatology, Molecular Biology, Genetics, Immunology and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 480 indexed citations. Recurring topics across this work include Connective tissue disorders research (3 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Systemic Lupus Erythematosus Research (2 papers), Spondyloarthritis Studies and Treatments (2 papers), MicroRNA in disease regulation (1 paper), Nanoplatforms for cancer theranostics (1 paper), Moyamoya disease diagnosis and treatment (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Cancer Research (166 citations), Rheumatology (132 citations), Immunology (122 citations), Molecular Biology (227 citations) and Genetics (65 citations). Nan Leng has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Ping Zhu, Dmitriy Ovcharenko, Charles D. Johnson, Kevin Kelnar, David Brown, Conghua Wang, Lina Chen, Rachel Morissette, Shujun Luo and Hugh Young Rienhoff. Their work appears in journals such as Medicine, European Journal of Cancer, Microchimica Acta, Archives of Biochemistry and Biophysics and Journal of Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.